Want to see CALC full AI Analyst Report?
CalciMedica (CALC) Stock Statistics & Valuation Metrics
Total Valuation
CalciMedica has a market cap or net worth of $9.97M. The enterprise value is $8.20M.
- Market Cap
- $9.97M
- Enterprise Value
- $8.20M
Share Statistics
CalciMedica has 6,828,292 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 6,828,292
- Owned by Insiders
- 35.37%
- Owned by Institutions
- 26.44%
Financial Efficiency
CalciMedica’s return on equity (ROE) is 4.45 and return on invested capital (ROIC) is -209.07%.
- Return on Equity (ROE)
- 4.45
- Return on Assets (ROA)
- -2.18
- Return on Invested Capital (ROIC)
- -209.07%
- Return on Capital Employed (ROCE)
- -2.36
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.97M
- Employee Count
- 15
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of CalciMedica is -0.21. CalciMedica’s PEG ratio is 0.05.
- PE Ratio
- -0.21
- PS Ratio
- 0.00
- PB Ratio
- 0.91
- Price to FCF
- -0.24
- Price to Operating Cash Flow
- -0.26
- PEG Ratio
- 0.05
Income Statement
In the last 12 months, CalciMedica had revenue of 0 and earned -29.56M in profits. Earnings per share was -9.85.
- Revenue
- 0
- Gross Profit
- -46.00K
- Operating Income
- -23.12M
- Pretax Income
- -29.56M
- Net Income
- -29.56M
- EBITDA
- -28.09M
- Earnings Per Share (EPS)
- -9.85
Cash Flow
In the last 12 months, operating cash flow was -19.11M and capital expenditures -14,000, giving a free cash flow of -19.12M billion.
- Operating Cash Flow
- -19.11M
- Free Cash Flow
- -19.12M
- Free Cash Flow per Share
- -5.59
Dividends & Yields
CalciMedica pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -415.90%
- Earnings Yield
- -425.37%
Stock Price Statistics
- Beta
- 0.18
- 52-Week Price Change
- -90.23%
- 50-Day Moving Average
- 1.77
- 200-Day Moving Average
- 3.45
- Relative Strength Index (RSI)
- 49.11
- Average Volume (3m)
- 82.04K
Important Dates
CalciMedica upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 11, 2026
- Next Earnings Date
- Nov 18, 2026
- Ex-Dividend Date
- ―
Financial Position
CalciMedica as a current ratio of 3.58, with Debt / Equity ratio of -146.06%
- Current Ratio
- 3.58
- Quick Ratio
- 3.58
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.06
- Interest Coverage Ratio
- -16.26
Taxes
In the past 12 months, CalciMedica has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
CalciMedica EV to EBITDA ratio is 0.70, with an EV/FCF ratio of 0.73.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.70
- EV to Free Cash Flow
- 0.73
- EV to Operating Cash Flow
- 0.73
Balance Sheet
CalciMedica has $18.62M in cash and marketable securities with $0.00 in debt, giving a net cash position of $18.62M billion.
- Cash & Marketable Securities
- $18.62M
- Total Debt
- $0.00
- Net Cash
- $18.62M
- Net Cash Per Share
- $2.73
- Tangible Book Value Per Share
- $1.61
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for CalciMedica is $9.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $9.00
- Price Target Upside
- 516.44% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 15.37%
Scores
- Smart Score
- ―
- AI Score
- 44